Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes

Hong, Soyon, Ostaszewski, Beth L., Yang, Ting, O’Malley, Tiernan T., Jin, Ming, Yanagisawa, Katsuhiko, Li, Shaomin, Bartels, Tim +1 more·2014·Neuron

DOI 10.1016/j.neuron.2014.02.027

Cited by (214)

Items 101–200 of 214

Chirality Dependence of Amyloid β Cellular Uptake and a New Mechanistic Perspective
Subrata Dutta, Thomas S. Finn, Ariel J. Kuhn, Benjamin S. Abrams, Jevgenij A. Raskatov · 2018 · ChemBioChem
Making biological membrane resistant to the toxicity of misfolded protein oligomers: a lesson from trodusquemine.
Silvia Errico, Giacomo Lucchesi, Davide Odino, Stefano Muscat, C. Capitini, Chiara Bugelli, C. Canale, R. Ferrando, Gianvito Grasso, D. Barbut et al. · 2020 · Nanoscale
Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies
Hai Yang, Jin‐Ping Li, Xiaoxiong Li, Linqiu Ma, Mingliang Hou, Huadong Zhou, Rui Zhou · 2022 · Frontiers in Molecular Neuroscience
AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer’s and Parkinson’s Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery
Coralie Di Scala, Nicholas Armstrong, Henri Chahinian, Éric Chabrière, Jacques Fantini, Nouara Yahi · 2022 · International Journal of Molecular Sciences
Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures
Clive Bate, Alun Williams · 2017 · Neurobiology of Disease
Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics
Aaron R. Ritter, Jeffrey L. Cummings · 2015 · Frontiers in Neurology
Evidence that small molecule enhancement of β-hexosaminidase activity corrects the behavioral phenotype in Dutch APPE693Q mice through reduction of ganglioside-bound Aβ
Elysse M. Knight, Hadis N. Williams, A. Christopher Stevens, S H Kim, Jessica Kottwitz, Andrika Morant, John Steele, William L. Klein, Katsuhiko Yanagisawa, R. E. BOYD et al. · 2014 · Molecular Psychiatry
Allium roseum L. extract inhibits amyloid beta aggregation and toxicity involved in Alzheimer’s disease
A. Boubakri, Manuela Leri, M. Bucciantini, H. Najjaa, A. Ben Arfa, M. Stefani, M. Neffati · 2019 · bioRxiv
Current understandings and perspectives of petroleum hydrocarbons in Alzheimer’s disease and Parkinson’s disease: a global concern
Rajalakshmi Rajendran, Roshni Pushpa Raghavan, Abdullah Godran Al-Sehemi, Md. Sahab Uddin, Lotfi Aleya, Bijo Mathew · 2022 · Environmental Science and Pollution Research
The function of sphingolipids in different pathogenesis of Alzheimer's disease: A comprehensive review
Wang, Xinyi, Li, Huaqiang, Sheng, Yunjie, He, Bingqian, Liu, Zeying, Li, Wanli, Yu, Shujie, Wang, Jiajing, Zhang, Yixin, Chen, Jianyu et al. · 2024 · Biomedicine & Pharmacotherapy
Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin
Manuela Leri, Francesco Bemporad, Reinier Oropesa‐Nuñez, Claudio Canale, Martino Calamai, Daniele Nosi, Matteo Ramazzotti, Sofia Giorgetti, Francesco Saverio Pavone, Vittorio Bellotti et al. · 2016 · Journal of Cellular and Molecular Medicine
Acute amnestic encephalopathy in amyloid-β oligomer–injected mice is due to their widespread diffusion in vivo
Stéphane Epelbaum, Ihsen Youssef, Pascale N. Lacor, Pierre Chaurand, Eric Duplus, Bernard Brugg, Charles J. Duyckaerts, Benoı̂t Delatour · 2015 · Neurobiology of Aging
Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides
Coralie Di Scala, Nouara Yahi, Alessandra Flores, Sonia Boutemeur, Nazim Kourdougli, Henri Chahinian, Jacques Fantini · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Rosetta Stone for Amyloid Fibrils: The Key Role of Ring-Like Oligomers in Amyloidogenesis
Oxana V. Galzitskaya, Olga M. Selivanova · 2017 · Journal of Alzheimer s Disease
Shear-Induced Amyloid Formation in the Brain: I. Potential Vascular and Parenchymal Processes
Trumbore, Conrad N. · 2016 · Journal of Alzheimer's Disease
New insight into brain disease therapy: nanomedicines-crossing blood–brain barrier and extracellular space for drug delivery
Ziqi Gu, Haishu Chen, Han Zhao, Wanting Yang, Yilan Song, Xiang Li, Yang Wang, Dan Du, Haikang Liao, Wenhao Pan et al. · 2022 · Expert Opinion on Drug Delivery
Analysis of Physicochemical Interaction of Aβ40 with a GM1 Ganglioside-Containing Lipid Membrane
Majid Vahed, Saburo Neya, Katsumi Matsuzaki, Tyuji Hoshino · 2018 · The Journal of Physical Chemistry B
Ganglioside GQ1b ameliorates cognitive impairments in an Alzheimer’s disease mouse model, and causes reduction of amyloid precursor protein
Min‐Kyoo Shin, Minsuk Choi, Hyang-Ji Chae, Jiwon Kim, Hong Gi Kim, Kil-Lyong Kim · 2019 · Scientific Reports
Single molecule experiments emphasize GM1 as a key player of the different cytotoxicity of structurally distinct Aβ1–42 oligomers
Martino Calamai, Elisa Evangelisti, Roberta Cascella, Niccoló Parenti, Cristina Cecchi, Massimo Stefani, Francesco Saverio Pavone · 2015 · Biochimica et Biophysica Acta (BBA) - Biomembranes
Interaction of toxic and non-toxic HypF-N oligomers with lipid bilayers investigated at high resolution with atomic force microscopy
Reinier Oropesa‐Nuñez, Silvia Seghezza, Silvia Dante, Alberto Diaspro, Roberta Cascella, Cristina Cecchi, Massimo Stefani, Fabrizio Chiti, Claudio Canale · 2016 · Oncotarget
Amyloid-β in Alzheimer’s disease – front and centre after all?
Caroline Weglinski, Alexander F. Jeans · 2022 · Neuronal Signaling
Under the umbrella of depression and Alzheimer’s disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?
Carla Fonseca, Miren Ettcheto, Joana Bicker, Maria José Fernandes, Amílcar C. Falcão, Antoni Camins, Ana C. Fortuna · 2023 · Ageing Research Reviews
The interactions of amyloid β aggregates with phospholipid membranes and the implications for neurodegeneration
Rima Budvytytė, Gintaras Valinčius · 2023 · Biochemical Society Transactions
AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer’s Disease Therapy
Fodil Azzaz, Henri Chahinian, Nouara Yahi, Jacques Fantini, Coralie Di Scala · 2023 · International Journal of Molecular Sciences
Dynamic effect of beta-amyloid 42 on cell mechanics
Qi Gao, Yuqiang Fang, Shiqing Zhang, Ho Sze Hersey Wong, Yee Edward Chan, Samantha Sze Man Wong, Ken Kin Lam Yung, King Wai Chiu Lai · 2019 · Journal of Biomechanics
Formaldehyde‐Crosslinked Nontoxic Aβ Monomers to Form Toxic Aβ Dimers and Aggregates: Pathogenicity and Therapeutic Perspectives
Hang Zhao, Xuerong Huang, Zhiqian Tong · 2021 · ChemMedChem
Regulation of Age-Related Protein Toxicity
Anita Pras, Ellen A. A. Nollen · 2021 · Frontiers in Cell and Developmental Biology
Gene Therapy Strategy for Alzheimer’s and Parkinson’s Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells
Assou El Battari, Léa Rodriguez, Henri Chahinian, Olivier Delézay, Jacques Fantini, Nouara Yahi, Coralie Di Scala · 2021 · International Journal of Molecular Sciences
Linking glycosphingolipids to Alzheimer’s amyloid-ß: extracellular vesicles and functional plant materials
Kohei Yuyama, Yasuyuki Igarashi · 2022 · Glycoconjugate Journal
Reduced retromer function results in the accumulation of amyloid-beta oligomers
Anna Ansell, Juan F. Reyes, My Samuelsson, Martin Hallbeck · 2018 · Molecular and Cellular Neuroscience
The Membrane Axis of Alzheimer's Nanomedicine
Yuhuan Li, Huayuan Tang, Nicholas Andrikopoulos, Ibrahim Javed, Luca Cecchetto, Aparna Nandakumar, Aleksandr Käkinen, Thomas Paul Davis, Feng Ding, Pu Chun Ke · 2020 · Advanced NanoBiomed Research
Calcitonin native prefibrillar oligomers but not monomers induce membrane damage that triggers NMDA-mediated Ca2+-influx, LTP impairment and neurotoxicity
Marcello Belfiore, Ida Cariati, Andrea Matteucci, Lucia Gaddini, Gianfranco Macchia, Raoul Fioravanti, Claudio Frank, Virginia Tancredi, Giovanna D’Arcangelo, Marco Diociaiuti · 2019 · Scientific Reports
Trends in glycolipid biomarker discovery in neurodegenerative disorders by mass spectrometry
Dehelean, Liana, Sarbu, Mirela, Petrut, Alina, Zamfir, Alina D. · 2019 · Advances in experimental medicine and biology
Amyloid β-Induced Inflammarafts in Alzheimer’s Disease
Shihui Ding, Soo‐Ho Choi, Yury I. Miller · 2025 · International Journal of Molecular Sciences
Reactivity of Flavonoids Containing a Catechol or Pyrogallol Moiety with Metal‐Free and Metal‐Associated Amyloid‐β
Seongmin Park, Yelim Yi, Mi Hee Lim · 2020 · Bulletin of the Korean Chemical Society
Redox Properties of Small Molecules Essential for Multiple Reactivities with Pathological Factors in Alzheimer's Disease
Mingeun Kim, Mi Hee Lim · 2021 · Bulletin of the Korean Chemical Society
Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
Kohei Yuyama, Hui Sun, Yasuyuki Igarashi, Kenji Monde, Takumi Hirase, Masato Nakayama, Yoichi Makino · 2022 · Alzheimer s Research & Therapy
A Unified View of Assessing the Pro‐oxidant versus Antioxidant Nature of Amyloid Beta Conformers
Suchitra Mitra, Pallavi Prasad, Saumen Chakraborty · 2018 · ChemBioChem
Downregulation of RBO-PI4KIIIα Facilitates Aβ42Secretion and Ameliorates Neural Deficits in Aβ42-ExpressingDrosophila
Xiao Zhang, Wen-An Wang, Li-Xiang Jiang, Haiyan Liu, Baozhu Zhang, Nastasia K.-H. Lim, Qing-Yi Li, Fu-De Huang · 2017 · Journal of Neuroscience
Assessment of the therapeutic potential of hesperidin and proteomic resolution of diabetes-mediated neuronal fluctuations expediting Alzheimer’s disease
Sapna Khowal, Malik M. A. Mustufa, Naveen K. Chaudhary, Samar Husain Naqvi, Suhel Parvez, Swatantra Kumar Jain, Saima Wajid · 2015 · RSC Advances
Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting
Karin E. Sandoval, KEN A. WITT · 2024 · Pharmacological Reviews
Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts
Youssef M. Mousa, Ihab M. Abdallah, Misako Hwang, Douglas R. Martin, Amal Kaddoumi · 2020 · Scientific Reports
Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model
Aline Freyssin, Agnès Rioux Bilan, Bernard Fauconneau, Laurent Galineau, Sophie Sérrière, Clovis Tauber, Flavie Perrin, Jérôme Guillard, Sylvie Chalon, Guylène Page · 2022 · Frontiers in Neuroscience
Ganglioside Micelles Affect Amyloid β Aggregation by Coassembly
Jing Hu, Sara Snogerup Linse, Emma Sparr · 2023 · ACS Chemical Neuroscience
Optimization of the Linker Length in the Dimer Model of E22P-Aβ40 Tethered at Position 38
Ayaka Chikugo, Yumi Irie, Chihiro Tsukano, Ayumi Uchino, Takahito Maki, Toshiaki Kume, Taiji Kawase, Kenji Hirose, Yusuke Kageyama, Ikuo Tooyama et al. · 2022 · ACS Chemical Neuroscience
Derailed Intraneuronal Signalling Drives Pathogenesis in Sporadic and Familial Alzheimer’s Disease
Tom Van Dooren, Katrien Princen, Koen De Witte, Gerard Griffioen · 2014 · BioMed Research International
The Amphipathic GM1 Molecule Stabilizes Amyloid Aggregates, Preventing their Cytotoxicity
Monica Bucciantini, Manuela Leri, Massimo Stefani, Ronald Melki, Sandra Zecchi‐Orlandini, Daniele Nosi · 2020 · Biophysical Journal
Role of Mitochondrial Calcium Dysregulation in Alzheimer’s Disease Pathogenesis
Rasoul Ebrahimi, Sara Hatami, Anahita Hashempoor, Soroush Oraee, Shakiba Salarvandian, Ali Faramarzi, Khadijeh Esmaeilpour · 2025 · Molecular Neurobiology
Toxic HypF-N Oligomers Selectively Bind the Plasma Membrane to Impair Cell Adhesion Capability
Reinier Oropesa‐Nuñez, Sandeep Keshavan, Silvia Dante, Alberto Diaspro, Benedetta Mannini, Claudia Capitini, Cristina Cecchi, Massimo Stefani, Fabrizio Chiti, Claudio Canale · 2018 · Biophysical Journal
Imaging Amyloid‐β Membrane Interactions: Ion‐Channel Pores and Lipid‐Bilayer Permeability in Alzheimer's Disease
John H. Viles · 2023 · Angewandte Chemie
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits
Laura Bellingacci, Jacopo Canonichesi, Miriam Sciaccaluga, Alfredo Megaro, Petra Mazzocchetti, Michela Di Mauro, Cinzia Costa, Massimiliano Di Filippo, Vito Enrico Pettorossi, Alessandro Tozzi · 2024 · International Journal of Molecular Sciences
Reprint of “Ganglioside lipids accelerate α-synuclein amyloid formation”
Ricardo Gaspar, Jon Pallbo, Ulrich Weininger, Sara Snogerup Linse, Emma Sparr · 2019 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
A Robust and Scalable High-Throughput Compatible Assay for Screening Amyloid-β-Binding Compounds
Richard McClure, Rey Redha, Paige N. Vinson, Wellington N. Pham · 2019 · Journal of Alzheimer s Disease
A novel neuroinflammation-responsive hydrogel based on mimicking naked mole rat brain microenvironment retards neurovascular dysfunction and cognitive decline in Alzheimer’s disease
Yufang Zhao, Shupei Qiao, Bosong Zhang, Yue Cao, Hui Tian, Runze Liu, Liuke Sun, Wang Fang Cao, Liang Li, Ruiqi L. Wang et al. · 2021 · Chemical Engineering Journal
Exercise for the prevention of Alzheimer's disease: Multiple pathways to promote non-amyloidogenic AβPP processing
Richard J. Elsworthy, Connor Dunleavy, Martin Whitham, Sarah Aldred · 2022 · Aging and Health Research
A stimuli-responsive polymer modified nanopore for measuring β-amyloid peptide and zinc ions in brains of live mice with Alzheimer's disease
Shushu Ding, Yue Zhu, Anwei Zhu, Guoyue Shi · 2023 · Sensors & Diagnostics
An unraveled mystery: What's the role of brain sphingolipids in neurodegenerative and psychiatric disorders
Xin‐Tian Bie, Maoxing Zhang, Qingyu Wang, Ying Wang · 2025 · Neurobiology of Disease
Entwined processes in Alzheimer's disease: Brain cellular senescence and Alzheimer's disease pathology
Wen Li, Ying Han, Peichang Wang, Song Qiao · 2025 · Alzheimer s & Dementia
Extracellular vesicles enriched with amylin receptor are cytoprotective against the Aß toxicity in vitro
Rania Soudy, Ryoichi Kimura, Wen Fu, Aarti Patel, Jack H. Jhamandas · 2022 · PLoS ONE
Profiling of glycosphingolipids with SCDase digestion and HPLC-FLD-MS
Radhika Chakraberty, Béla Reiz, Christopher W. Cairo · 2021 · Analytical Biochemistry
The Janus face of CaMKII: from memory consolidation to neurotoxic switch in Alzheimer’s disease
Luhong Tang, Feng Liu, Xuefei Sun, Jiaoyan Yang, Yifang Liu, Xueting Pan, Liying Hao, Fan Lou, Jingyang Su · 2025 · Archives of Toxicology
Molecular dynamics study of water channels in natural and synthetic amyloid-β fibrils
Sachin R. Natesh, Alexander R Hummels, Joseph R. Sachleben, Tobin R. Sosnick, Karl F. Freed, Jack F. Douglas, Stephen C. Meredith, Esmael J. Haddadian · 2021 · The Journal of Chemical Physics
NEU1-Mediated Extracellular Vesicle Glycosylation in Alzheimer’s Disease: Mechanistic Insights into Intercellular Communication and Therapeutic Targeting
Mohd Adnan, Arif Jamal Siddiqui, Fevzi Bardakçi, Malvi Surti, Riadh Badraoui, Mitesh B. Patel · 2025 · Pharmaceuticals
Role of Electrostatic Interactions in Calcitonin Prefibrillar Oligomer-Induced Amyloid Neurotoxicity and Protective Effect of Neuraminidase
Ida Cariati, Roberto Bonanni, Mario Marini, Anna Maria Rinaldi, Beatrice Zarrilli, Virginia Tancredi, Claudio Frank, Giovanna D’Arcangelo, Marco Diociaiuti · 2021 · International Journal of Molecular Sciences
Inhibition of NMDA Receptor Activation in the Rostral Ventrolateral Medulla by Amyloid-β Peptide in Rats
Md Sharyful Islam, Chih‐Chia Lai, Lan-Hui Wang, Hsun‐Hsun Lin · 2023 · Biomolecules
Alzheimer’s Disease: From Pathogenesis to Emerging Therapeutic Targets
Tetsuya Takahashi, Kazuki Muguruma · 2026 · Journal of Clinical Medicine
From Lipids to Mitochondria: Shared Metabolic Alterations in Obesity and Alzheimer’s Disease
Romina María Uranga, Shailaja Kesaraju Allani · 2026 · Cells
Peripheral Delivery of Ganglioside GM1 Exacerbates the Pathogenesis of Alzheimer’s Disease in a Mouse Model
Chuang-Chuang Yang, Yuan Cheng, Haimei Yang, Yang Chen, Yan‐Jiang Wang, Zhi-Qiang Xu, Ye‐Ran Wang · 2021 · Neuroscience Bulletin
Brain lipid profiles and oligodendrocyte gene expression show discordant responses to high-fat diet in Alzheimer’s disease mice
Noe Kawade, Okiru Komine, Akira Sobue, Chihiro Kakimi, Miyako Tanaka, Takayoshi Suganami, Mayuko Shimada, Tomoo Ogi, Kazutaka Ikeda, Mai Horiuchi et al. · 2026 · Scientific Reports
Neurochemical Aspects of Alzheimer Disease
A. A. Farooqui · 2016 · Springer eBooks
Not all plaques are created equal: Uncovering a unique molecular signature in Alzheimer’s disease
Kristján Holt, Emily Payne, Tara L. Spires‐Jones · 2024 · Brain and Neuroscience Advances
Targeting Aβ Receptors to Modify Alzheimer’s Disease Progression
Laura T. Haas, Stephen M. Strittmatter · 2016 · Elsevier eBooks
Aβ40 Oligomers Promote Survival and Early Neuronal Differentiation of Dentate Gyrus-Isolated Precursor Cells Through Activation of the Akt Signaling Pathway
Maria‐del‐Carmen Silva‐Lucero, Laura Gomez‐Virgilio, Leonardo Ortíz‐López, Gerardo Bernabé Ramírez-Rodríguez, Marco Antonio Meraz‐Ríos · 2020 · Neurotoxicity Research
Sevoflurane Exposure of Clinical Doses in Pregnant Rats Induces Vcan Changes without Significant Neural Apoptosis in the Offspring
Yi Jin, Yu Wei, Xiaoxue Hu, Fanhua Meng, Qing Luo, Zhilan Chen, Zeyong Yang · 2023 · Medicina
Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
Natalia Salvadores, Inés Moreno‐González, Nazaret Gamez, Gabriel Quiroz, Laura Vegas, Marcela Escandón, Sebastián Jiménez, Javier Vitórica, Antonia Gutiérrez, Claudio A. Soto et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
Yuhan Xie, Xue Wei Meng, Tao Li, Haifeng Zhang, Yaonan Zheng, Sang-Yun Kim, Chen Zhang, Xin Yu, Huali Wang · 2025 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Global C3 lowering in adulthood protects against hippocampal dysfunction and cognitive impairment in aged mice
André F. Batista, Jessey Presumey, Brijendra Bahadur Singh, Esra Yalçın, Maren K. Schroeder, Khyrul Khan, Emma Spooner, Shaomin A Li, Michael C. Carroll, Cynthia Ann Lemere · 2025 · Molecular Neurodegeneration Advances
Alzheimer’s Disease
Jacques Fantini, Nouara Yahi · 2015 · Elsevier eBooks
Aβ Fibrils Can Act as Aqueous Pores: a Molecular Dynamics Study
Sashin Natesh, Joseph R. Sachleben, Tobin R. Sosnick, Karl F. Freed, Stephen C. Meredith, Esmael J. Haddadian · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
Abnormalities of Amyloid Precursor Protein in the Etiology of Alzheimer’s disease
Mostafa I. Waly · 2015 · Canadian Journal of Clinical Nutrition
The Complex Pathways to Mechanism-Based Therapeutics in Alzheimer’s Disease
Dennis J. Selkoe · 2016 · Elsevier eBooks
Investigating the role of normal and abnormal beta-amyloid processing in cognition
Thomas J. Freeman · 2019 · ORCA Online Research @Cardiff (Cardiff University)
The Involvement of Cellular Glycans in Alzheimer's Disease
Yasuhiko Kizuka · 2020 · Elsevier eBooks
Effects of anle138b treatment on amyloid-β neurotoxicity
Carolina Thomas · 2020
A Model Of Agitated Behavioral Symptoms In Persons With Alzheimer Disease
Katherine Kero · 2020 · Human Biology
Proteotoxicity and Autophagy in Neurodegenerative and Cardiovascular Diseases
Kevin Michael Alexander, Isabel M Morgado, Ronglih Liao · 2021 · Advances in biochemistry in health and disease
Glycosphingolipids and central nervous system–related diseases
Zhongwu Guo · 2024 · Elsevier eBooks
Additional file 6 of Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
Kohei Yuyama, Hui Sun, Yasuyuki Igarashi, Kenji Monde, Takumi Hirase, Nakayama, Masato, Yoichi Makino · 2022 · Figshare
Alzheimer’s Disease: Link to Biomolecular Mechanisms and Clinical Pathologies
Duygu Gezen‐Ak, Erdinç Dursun · 2024
Potential anti-amyloid beta oligomerization effects of PD166793 in Alzheimer's disease
Danyeong Kim, KyuHwan Shim, Jinho Kim, Geon Ko, Mario A. Tan, Keun-A Chang, Seong Soo A. An · 2025 · Experimental Neurology
Additional file 2 of Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
Kohei Yuyama, Sun, Hui, Yasuyuki Igarashi, Monde, Kenji, Takumi Hirase, Nakayama, Masato, Yoichi Makino · 2022 · Figshare
Additional file 4 of Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
Kohei Yuyama, Sun, Hui, Igarashi, Yasuyuki, Monde, Kenji, Takumi Hirase, Nakayama, Masato, Yoichi Makino · 2022 · Figshare
Additional file 5 of Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
Kohei Yuyama, Sun, Hui, Igarashi, Yasuyuki, Monde, Kenji, Takumi Hirase, Nakayama, Masato, Yoichi Makino · 2022 · Figshare
Additional file 1 of Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
Kohei Yuyama, Sun, Hui, Yasuyuki Igarashi, Monde, Kenji, Takumi Hirase, Nakayama, Masato, Yoichi Makino · 2022 · Figshare
Additional file 3 of Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
Kohei Yuyama, Sun, Hui, Igarashi, Yasuyuki, Monde, Kenji, Takumi Hirase, Nakayama, Masato, Yoichi Makino · 2022 · Figshare
Cholesterol and sphingolipids in Alzheimer's disease
Sabrina Cajuste, Daniella Devaney, Valentina Farr, Sanjoy K. Bhattacharya · 2025 · Elsevier eBooks
Mitigation of Aβ neurotoxicity in Alzheimer's disease using a non-toxic platinum complex derived from retinamide
Chengyuan Qian, Yicun Shang, Linxiang Cai, Yunhua Zhang, Chengyan Chu, Zijian Guo, Xiaoyong Wang · 2025 · Inorganic Chemistry Frontiers
Etude préclinique et clinique de la phase précoce de la maladie d'Alzheimer
Stéphane Epelbaum · 2015 · theses.fr (ABES)
Comparaison des effets de la viniférine et du resvératrol dans des modèles expérimentaux de la maladie d'Alzheimer
Aline Freyssin · 2020 · theses.fr (ABES)
Tunable acoustic rotation for deep biophysical phenotyping of preclinical Alzheimer's disease
Yuxin Wang, Yue Quan, Shizheng Zhou, Yinning Zhou · 2026 · Materials Today Bio